Melissa A Sheiko1, Lucy Golden-Mason2, Silvia Giugliano2, Christine Waasdorp Hurtado1, Cara L Mack1, Michael R Narkewicz1, Hugo R Rosen3. 1. Department of Pediatrics, Digestive Health Institute, Children's Hospital Colorado, University of Colorado Denver School of Medicine, Aurora, CO. 2. Division of Gastroenterology and Hepatology, Hepatitis C Center, Department of Medicine, University of Colorado Denver, Aurora, CO. 3. Division of Gastroenterology and Hepatology, Hepatitis C Center, Department of Medicine, University of Colorado Denver, Aurora, CO; Eastern Colorado Veteran's Affairs Medical Center, Denver, CO. Electronic address: Hugo.Rosen@UCDENVER.edu.
Abstract
OBJECTIVES: To assess if peripheral T cell populations in children with chronic hepatitis C virus (HCV) infection would show evidence of activation/exhaustion and an attenuated functional response. STUDY DESIGN: Compared with adults, children with HCV infection have a higher rate of spontaneous viral clearance. In adults, chronic HCV has been linked to T cell exhaustion. Little is known of the immune status of children with HCV. Peripheral blood mononuclear cells were isolated from 16 children with HCV (6 males, 10 females; mean age 8.6 years, range 2-17), 16 age- and sex-matched control children without HCV infection, and 20 adults with chronic HCV. Multiparameter flow cytometry was performed to characterize T cell differences across the 3 groups. RESULTS: Controls and children with HCV had similar levels of CD4(+), CD8(+), and γδ(+) T cells. Children with HCV demonstrated a decrease in naïve T cells compared with control children and increased activation/exhaustion marker expression on both CD8(+) and CD4(+) T cells. Transcription factor analysis suggested functional activation of T cells in children with HCV; however, only the CD4(+) subset had enhanced cytokine production (interferon gamma and interleukin-2) compared with control children. CONCLUSIONS: The HCV response in children is characterized by several changes in T cell phenotype. Many of these changes, such as increased T cell expression of programmed cell death-1, are similar to responses in adults. Of note, cytokine production by CD4(+) helper T cells is increased in children with HCV compared with age- and sex-matched control children, which may influence long-term prognosis in children with HCV.
OBJECTIVES: To assess if peripheral T cell populations in children with chronic hepatitis C virus (HCV) infection would show evidence of activation/exhaustion and an attenuated functional response. STUDY DESIGN: Compared with adults, children with HCV infection have a higher rate of spontaneous viral clearance. In adults, chronic HCV has been linked to T cell exhaustion. Little is known of the immune status of children with HCV. Peripheral blood mononuclear cells were isolated from 16 children with HCV (6 males, 10 females; mean age 8.6 years, range 2-17), 16 age- and sex-matched control children without HCV infection, and 20 adults with chronic HCV. Multiparameter flow cytometry was performed to characterize T cell differences across the 3 groups. RESULTS: Controls and children with HCV had similar levels of CD4(+), CD8(+), and γδ(+) T cells. Children with HCV demonstrated a decrease in naïve T cells compared with control children and increased activation/exhaustion marker expression on both CD8(+) and CD4(+) T cells. Transcription factor analysis suggested functional activation of T cells in children with HCV; however, only the CD4(+) subset had enhanced cytokine production (interferon gamma and interleukin-2) compared with control children. CONCLUSIONS: The HCV response in children is characterized by several changes in T cell phenotype. Many of these changes, such as increased T cell expression of programmed cell death-1, are similar to responses in adults. Of note, cytokine production by CD4(+) helper T cells is increased in children with HCV compared with age- and sex-matched control children, which may influence long-term prognosis in children with HCV.
Authors: I Mozer-Lisewska; G Dworacki; E Kaczmarek; W Sluzewski; M Kaczmarek; A Woźniak; J Zeromski Journal: Scand J Immunol Date: 2006-04 Impact factor: 3.487
Authors: M Vogt; T Lang; G Frösner; C Klingler; A F Sendl; A Zeller; B Wiebecke; B Langer; H Meisner; J Hess Journal: N Engl J Med Date: 1999-09-16 Impact factor: 91.245
Authors: A Giovannetti; F Mazzetta; R Coviello; A M Casadei; M R Sartorerri; M Marziali; M Pierdominici; D Kuonen; A M Pesce; M Fiorilli; F Aiuti; I Quinti Journal: Viral Immunol Date: 2001 Impact factor: 2.257
Authors: Nicole Joller; Jason P Hafler; Boel Brynedal; Nasim Kassam; Silvia Spoerl; Steven D Levin; Arlene H Sharpe; Vijay K Kuchroo Journal: J Immunol Date: 2011-01-03 Impact factor: 5.422
Authors: C García-Monzón; P Jara; M Fernández-Bermejo; L Hierro; E Frauca; C Camarena; C Díaz; A De la Vega; J Larrauri; C García-Iglesias; M J Borque; P Sanz; L García-Buey; J A Moreno-Monteagudo; R Moreno-Otero Journal: Hepatology Date: 1998-12 Impact factor: 17.425
Authors: Estéfani García-Ríos; Alejandra Leivas; Francisco J Mancebo; Laura Sánchez-Vega; Diego Lanzarot; José María Aguado; Joaquín Martínez-López; María Liz Paciello; Pilar Pérez-Romero Journal: Biomedicines Date: 2022-03-09